These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8908461)

  • 21. Empiric antibiotic therapy for intraabdominal infections.
    Nichols RL
    Rev Infect Dis; 1983; 5 Suppl 1():S90-7. PubMed ID: 6342104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial therapy for intraabdominal infection.
    Nathens AB; Rotstein OD
    Am J Surg; 1996 Dec; 172(6A):1S-6S. PubMed ID: 9003683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of antibiotic treatment in surgical infections of the abdomen. Undesired effects of antibiotics and future studies.
    Dellinger EP
    Eur J Surg Suppl; 1996; (576):29-31; discussion 31-2. PubMed ID: 8908466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study.
    Larsson PG; Platz-Christensen JJ; Dalaker K; Eriksson K; Fåhraeus L; Irminger K; Jerve F; Stray-Pedersen B; Wölner-Hanssen P
    Acta Obstet Gynecol Scand; 2000 May; 79(5):390-6. PubMed ID: 10830767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical basis of macrolides apply in diseases of the respiratory tract].
    Płusa T
    Pol Merkur Lekarski; 2008 Nov; 25(149):432-6. PubMed ID: 19177783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anaerobes in children's acute abdomen].
    Veselyĭ SV
    Khirurgiia (Mosk); 1999; (5):34-6. PubMed ID: 10358968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cephalosporins in overcoming beta-lactamase-producing bacteria and preservation of the interfering bacteria in the treatment of otitis, sinusitis and tonsillitis.
    Brook I
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):939-50. PubMed ID: 18039079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do cultures contribute to optimisation of antibiotic therapy in the intensive care unit?
    Schurink CA; Hoitsma M; Rozenberg-Arska M; Joore JC; Hoepelman IM; Bonten MJ
    Int J Antimicrob Agents; 2004 Apr; 23(4):325-31. PubMed ID: 15081079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic therapy for severe bacterial infections: correlation between the inhibitory quotient and outcome.
    Spanu T; Santangelo R; Andreotti F; Cascio GL; Velardi G; Fadda G
    Int J Antimicrob Agents; 2004 Feb; 23(2):120-8. PubMed ID: 15013036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibiotic resistance in respiratory tract infections: what can we do?].
    Flückiger U
    Praxis (Bern 1994); 2001 May; 90(21):931-4. PubMed ID: 11441707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic use in dental practice. A review.
    Poveda Roda R; Bagan JV; Sanchis Bielsa JM; Carbonell Pastor E
    Med Oral Patol Oral Cir Bucal; 2007 May; 12(3):E186-92. PubMed ID: 17468711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A consensus statement on the standardized application of antibacterial agents in biliary tract surgery (2019)].
    ; ;
    Zhonghua Wai Ke Za Zhi; 2019 Jul; 57(7):481-487. PubMed ID: 31269607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Lactobacillus F19 on the emergence of antibiotic-resistant microorganisms in the intestinal microflora.
    Sullivan A; Johansson A; Svenungsson B; Nord CE
    J Antimicrob Chemother; 2004 Oct; 54(4):791-7. PubMed ID: 15329362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Completing a course of drug therapy is necessary to combat the infection, not to discourage emergence of resistance].
    van der Meer JW; Natsch S
    Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1720-2. PubMed ID: 15468900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duration of antibiotic treatment in surgical infections of the abdomen. The role of shock.
    Bergstein JM
    Eur J Surg Suppl; 1996; (576):16-8. PubMed ID: 8908463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Septic complications after biliary tract stone surgery: a review and report of the European prospective study.
    Cainzos M; Sayek I; Wacha H; Pulay I; Dominion L; Aeberhard PF; Hau T; Aasen AO
    Hepatogastroenterology; 1997; 44(16):959-67. PubMed ID: 9261583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing drug exposure to minimize selection of antibiotic resistance.
    Olofsson SK; Cars O
    Clin Infect Dis; 2007 Sep; 45 Suppl 2():S129-36. PubMed ID: 17683017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.